{
    "nct_id": "NCT03486821",
    "official_title": "Pilot Trial of Ultra-hypofractionated Radiation in Early Prostate Cancer",
    "inclusion_criteria": "* Ability of participant to sign a written informed consent.\n* Diagnosed with prostate cancer, T1-T2bN0M0 GS6-7, PSA < 20\n* IPSS score < 15 (and < 10 if on medication for benign prostatic hypertrophy such as tamsulosin) at time of enrollment (Appendix 21.4)\n* Prostate volume (by US, CT or MRI measurement) < 50 cc at time of enrollment\n* Androgen deprivation therapy based on clinician judgment is permitted on study\n* Life expectancy > 10 years based on clinician's judgment\n* No other active malignancy\n* Age â‰¥ 18 years\n* Performance Status Eastern Cooperative Oncology Group (ECOG) 0-1 (Appendix 21.5).\n* Other study-specific criteria:\n* Men of child-bearing potential must not donate sperm while on this study and for 90 days after their last study treatment.\n\nNOTE: Acceptable forms of birth control are listed below:\n\n* One Barrier method (cervical cap with spermicide plus male condom; diaphragm with spermicide plus male condom) PLUS\n* Hormonal method (oral contraceptives, implants, or injections) or an intrauterine device (e.g., Copper-T).\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Current or anticipated use of other investigational agents while participating in this study.\n* Psychiatric illness/social situations that would limit compliance with study requirements\n* Prior pelvic radiation therapy\n* Prior prostatectomy\n* Inflammatory bowel disease or connective tissue disease requiring medical management",
    "miscellaneous_criteria": ""
}